Nucleolus in apoptosis-induced mouse preimplantation embryos.
Apoptosis may occur in early embryos in which the execution of essential developmental events has failed. Thus the initiation of the apoptotic mechanism may be related to activation of the embryonic genome. In this way, developmentally incompetent cells or whole embryos are eliminated. It is likely that some link exists between failed resumption of rRNA synthesis and the incidence of apoptosis in cleaving embryos. In this context, decreased developmental potential in cleaving nucleotransferred embryos is consistent with cell loss, and very likely due to programmed cell death. The effects of apoptosis inducers on cleaving embryos have not been characterised in comparable detail to that in the case of somatic cells. Early embryos provide a very good model for study of these processes because of the specificity of rRNA transcription resumption after fertilization. In our experiments three apoptosis inducers (staurosporin 10 mM, actinomycin D 0.05 mg/ml and camptothecin 0.1 mg/ml) were used in a culture medium for 15 h at the 4-cell stage (day 2) of mouse embryos, followed by further development in a pure culture medium until fixation on days 3, 4 and 5. In staurosporin-induced embryos, light microscopy immunostaining of nucleolar proteins (fibrillarin, Nopp140, protein B23) did not reveal changes in nucleolar morphology on day 3. On days 4 and 5, more compact (roundish) nucleoli (in comparison with controls) were observed. The embryos treated with camptothecin displayed a similar staining pattern to those with staurosporin at each day. In actinomycin-D-treated embryos, marked changes in nucleolar appearance were visible as early as day 3. These changes in nucleolar morphology consisted of loss of the reticulation appearance and fragmentation of nucleoli. In addition to nucleolar changes, significantly decreased cell proliferation was observed. The induced embryos did not reach the blastocyst stage. The number of blastomeres was decreased, and staining with Hoechst 33342 revealed a significant percentage of apoptotic nuclei (condensed/fragmented nuclei) from day 4.
Baran
V
V
Institute of Animal Physiology, Slovak Academy of Sciences, Soltésovej 4, 040 01 Kosice, Slovakia.
Fabian
D
D
Rehak
P
P
Koppel
J
J
D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D015415:Biomarkers / Q000032:analysis; D001755:Blastocyst / Q000166:cytology* / Q000187:drug effects / Q000502:physiology; D001757:Blastomeres / Q000166:cytology / Q000502:physiology; D002166:Camptothecin / Q000494:pharmacology; D002466:Cell Nucleolus; D002470:Cell Survival; D002868:Chromosomal Proteins, Non-Histone / Q000032:analysis / Q000378:metabolism; D003609:Dactinomycin / Q000494:pharmacology; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect / Q000379:methods; D051379:Mice; D008813:Mice, Inbred ICR; D009687:Nuclear Proteins / Q000032:analysis / Q000378:metabolism; D000090243:Nucleophosmin; D010750:Phosphoproteins / Q000032:analysis / Q000378:metabolism; D011247:Pregnancy; D019311:Staurosporine / Q000494:pharmacology
D015415:Biomarkers; D002868:Chromosomal Proteins, Non-Histone; C075564:NOLC1 protein, human; C513068:Nolc1 protein, mouse; C000715570:Npm1 protein, mouse; D009687:Nuclear Proteins; D010750:Phosphoproteins; C047458:fibrillarin; D000090243:Nucleophosmin; D003609:Dactinomycin; D019311:Staurosporine; D002166:Camptothecin